Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 81 results for "neuland laboratories"

Neuland Laboratories standalone net profit declines 71.89% in ...

Sales decline 20.74% to Rs 101.95 crore Net profit of Neuland Laboratories declined 71.89% to Rs 1.92 crore in the quarter ended December 2014 as against Rs 6.83 crore during the previous quarter ended December 2013. Sales declined 20.74% to Rs 101.95 crore ... Business Standard, 23 hours ago

Neuland Labs' revenues for third quarter of FY 2015 decrease 17% to $17.14 million

Neuland Laboratories Ltd., (NSE: NEULANDLAB; BSE-Scrip Code:524558), a pharmaceutical manufacturer providing active pharmaceutical ingredients (APIs), complex intermediates and custom manufacturing solutions services to customers located in 85 ...
 News-Medical.Net21 hours ago Neuland Labs Reports Third Quarter Fiscal Year 2015 Financial Results  RCL Advisors22 hours ago Neuland Labs Reports Another Successful FDA Audit And Wins 2015 CMO Leadership Award  TickerTech.com5 days ago
[x]  

NEULAND LABORATORIES : Announces Change in Director

Neuland Laboratories Limited has informed the Exchange that Export Import Bank of India ( EXIM Bank ) has withdrawn the nomination of Mr.Nadeem Panjetan as a Director on the Board of Company , w.e.f. December 8, 2014 . Consequently, Mr. Nadeem ...
 4 Traders1 month ago NEULAND LABORATORIES : EXIM Bank withdraws nominee director from Neuland Laboratories Ltd  4 Traders1 month ago EXIM Bank withdraws nomination of Nadeem Panjetan as director of Neuland Laboratories  Money Control1 month ago Neuland Laboratories allots equity shares on rights basis  Money Control1 month ago

Neuland Laboratories to hold board meeting

On 30 January 2015
 Business Standard3 weeks ago Neuland Laboratories Ltd to consider Q3 results on Jan 30, 2015  Equity Bulls3 weeks ago

Indian regulatory system needs to be strengthened to improve clinical trial industry in India: Neuland labs CFO

As the clinical trial industry is facing lot of resistance in India, Industry experts are of the view that the Indian regulatory system should undergo massive reforms to contain unethical practices in clinical trials and should pave way to open up ...
 PharmaBiz1 month ago

Ministry of Finance of Republic of India : Government approves fifteen (15) proposals of Foreign Direct Investment (FDI) amounting to about Rs. 689.35 Crore

Based on the recommendations of Foreign Investment Promotion Board (FIPB) in its meeting held on November 14, 2014, the Central Government has approved fifteen (15) proposals of Foreign Direct Investment (FDI) amounting to Rs. 689.35 crore ...
 4 Traders1 month ago

Net sales of 50 major pharma cos up by 14%, EBDITA by 15.5% in first half of 2014-15

Despite reduction in prices of several medicines by NPPA, quality problems with US FDA, competition and slowdown in approvals, 50 top Indian pharmaceutical companies registered satisfactory growth in net sales and earnings before depreciation, ...
 PharmaBiz2 months ago
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less